The role of c-Myc in breast cancer has been extensively examined in many studies for the past decade [6]; however, specifically reducing its level by genetic means in established breast cancer cell lines is still helpful for a better understanding of its role in maintaining the malignant phenotype. This evidence concerns the gene MYC and breast carcinoma.